In 2016, Riddell filed suit against Schutt and Xenith, alleging that certain helmets containing an integral raised central band, aligned vent holes and/or a removable face mask infringed three Riddell patents regarding the same. Schutt and Xenith filed six IPR’s challenging nearly 100 claims, many of the claims being challenged on multiple grounds. Riddell retained […]
McAndrews secured a complete victory for its client Fibar USA LLC when on June 27, 2019 Pinek IP LLC dismissed its lawsuit against Fibar in the United States District Court of the Northern District of Illinois Eastern Division. Chicago-based Fibar is a unit of wireless smart home and home automation company Fibar Group S.A. based […]
McAndrews secured a complete victory for its client TQ Delta LLC, a technology development and licensing firm, when a Delaware federal jury found that 2Wire Inc. infringed three of TQ Delta’s patents related to Digital Subscriber Line (“DSL”) technology. 2Wire is a subsidiary of ARRIS Solutions, which was recently acquired by CommScope Inc. The jury’s […]
McAndrews shareholders Patrick J. Arnold and Edward A. Mas II secured dismissal of an opposition proceeding in a trademark opposition before the Trademark Trial and Appeal Board (TTAB) for client AbbVie Biotechnology Ltd.
McAndrews shareholders, Sharon Hwang, Deborah Laughton, and Stephanie Samz, have won an affirmance from the U.S. Court of Appeals for the Federal Circuit of a $254 million judgment for Stryker Corporation in one of the largest enhanced damage awards in patent history.
McAndrews announced today that the Federal Circuit has affirmed four decisions of the Patent Trial and Appeal Board (“PTAB”), in favor of its client, Netlist, Inc.
Patent Trial and Appeal Board Finds All Claims of a Patent Owned by LiquidPower Specialty Products Unpatentable
On November 1, 2017, the Patent Trial and Appeal Board issued the public version of its final written decision in favor of firm client Baker Hughes, a GE Company LLC, finding that all claims of a patent owned by LiquidPower Specialty Products (“LSPI”) are unpatentable on all three grounds asserted in the Baker Hughes petition for inter partes review.
On August 25, 2017, the U.S. Court of Appeals vacated a decision of the Patent Trial and Appeal Board (“PTAB”) that had rejected all of the claims of a patent application owned by Stepan Company. The inventions of the Stepan application relate to an improved herbicidal surfactant formulation that provides significant manufacturing and processing benefits.